{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Lian S"],"funding":["China Scholarship Council","Research Grants Council, University Grants Committee","Swedish Research Council"],"pagination":["109701"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC11053305"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["27(5)"],"pubmed_abstract":["Genome-wide circulating cell-free DNA (ccfDNA) fragmentation for cancer detection has been rarely evaluated using blood samples collected before cancer diagnosis. To evaluate ccfDNA fragmentation for detecting early hepatocellular carcinoma (HCC), we first modeled and tested using hospitalized HCC patients and then evaluated in a population-based study. A total of 427 samples were analyzed, including 270 samples collected prior to HCC diagnosis from a population-based study. Our model distinguished hospital HCC patients from controls excellently (area under curve 0.999). A high ccfDNA fragmentation score was highly associated with an advanced tumor stage and a shorter survival. In evaluation, the model showed increasing sensitivities in detecting HCC using 'pre-samples' collected ≥4 years "],"journal":["iScience"],"pubmed_title":["Circulating DNA genome-wide fragmentation in early detection and disease monitoring of hepatocellular carcinoma."],"pmcid":["PMC11053305"],"funding_grant_id":["201808440263","T12-101/23-N","LC230003","11103024","202001418"],"pubmed_authors":["Zheng Z","Xie Y","Liang X","Li F","Fang F","Lu C","Wu B","Zhou W","Du Y","Deng L","Ai L","Gong X","Ji M","Liu Z","Wang P","Lian S","Yu X","Zhan J","Quan W","Yuan Y"],"additional_accession":[]},"is_claimable":false,"name":"Circulating DNA genome-wide fragmentation in early detection and disease monitoring of hepatocellular carcinoma.","description":"Genome-wide circulating cell-free DNA (ccfDNA) fragmentation for cancer detection has been rarely evaluated using blood samples collected before cancer diagnosis. To evaluate ccfDNA fragmentation for detecting early hepatocellular carcinoma (HCC), we first modeled and tested using hospitalized HCC patients and then evaluated in a population-based study. A total of 427 samples were analyzed, including 270 samples collected prior to HCC diagnosis from a population-based study. Our model distinguished hospital HCC patients from controls excellently (area under curve 0.999). A high ccfDNA fragmentation score was highly associated with an advanced tumor stage and a shorter survival. In evaluation, the model showed increasing sensitivities in detecting HCC using 'pre-samples' collected ≥4 years ","dates":{"release":"2024-01-01T00:00:00Z","publication":"2024 May","modification":"2026-06-01T17:15:59.884Z","creation":"2025-07-25T03:08:05.49Z"},"accession":"S-EPMC11053305","cross_references":{"pubmed":["38680658"],"doi":["10.1016/j.isci.2024.109701"]}}